Jaguar Health, Inc. Forecast, price target & analysts
Jaguar Health, Inc. Target price 2026 - Analyst rating & recommendation
Jaguar Health, Inc. Classifications & Recommendation
Jaguar Health, Inc. Price Target
| Target Price | $16.32 |
| Price | $3.95 |
| Potential |
313.17%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Jaguar Health, Inc. 2027 .
The average Jaguar Health, Inc. target price is $16.32.
This is
313.17%
register free of charge
$16.80
325.32%
register free of charge
$16.16
309.11%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Jaguar Health, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Jaguar Health, Inc. stock has an average upside potential 2027 of
313.17%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 11.51 | 18.60 |
| 1.54% | 61.60% | |
| Net Margin | -465.51% | -151.38% |
| 41.38% | 67.48% |
3 Analysts have issued a sales forecast Jaguar Health, Inc. 2026 . The average Jaguar Health, Inc. sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $11.5m | 1.54% |
|---|---|---|
| 2026 |
$18.6m
61.60%
unlock
|
|
1 Analyst has issued an EBITDA forecast Jaguar Health, Inc. 2026 . The average Jaguar Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $-43.2m | 49.33% |
|---|---|---|
| 2026 |
$2.8m
106.49%
unlock
|
|
EBITDA Margin
| 2025 | -375.33% | 51.66% |
|---|
3 Jaguar Health, Inc. Analysts have issued a net profit forecast 2026. The average Jaguar Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $-53.6m | 39.20% |
|---|---|---|
| 2026 |
$-28.2m
47.44%
unlock
|
|
Net Margin
| 2025 | -465.51% | 41.38% |
|---|---|---|
| 2026 |
-151.38%
67.48%
unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -803.95 | -5.79 |
| 99.29% | 99.28% | |
| P/E | negative | |
| EV/Sales | 1.05 |
3 Analysts have issued a Jaguar Health, Inc. forecast for earnings per share. The average Jaguar Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $-803.95 | 99.29% |
|---|---|---|
| 2026 |
$-5.79
99.28%
unlock
|
|
P/E ratio
| Current | -0.06 | 79.94% |
|---|---|---|
| 2026 |
-0.68
1,014.75%
unlock
|
|
Based on analysts' sales estimates for 2026, the Jaguar Health, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.70 | 77.56% |
|---|---|---|
| 2026 |
1.05
49.39%
unlock
|
|
P/S ratio
| Current | 0.28 | 31.77% |
|---|---|---|
| 2026 |
0.41
49.49%
unlock
|
|
Jaguar Health, Inc....
Current Jaguar Health, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| First Berlin |
Locked
➜
Locked
|
Locked | May 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
First Berlin:
Locked
➜
Locked
|
May 19 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
